PHARMACY

Report: Loblaw looks to sell medical marijuana

BY DSN STAFF
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NACDS Foundation launches Zika prevention campaign in Puerto Rico

BY David Salazar
ARLINGTON, Va. — The National Association of Chain Drug Stores Foundation on Friday announced that it would be rolling out a radio and online Zika Virus prevention campaign on May 9. The initiative is aimed at encouraging women to speak to physicians and pharmacists about how to protect themselves and their unborn children from the effects of Zika, which include microcephaly in children or loss of pregnancy.  
 
“The NACDS Foundation is taking this action to help address an imminent public health need, by helping to educate and empower women in Puerto Rico about where they can turn to help protect themselves and their unborn children,” said Kathleen Jaeger, president of the NACDS Foundation. “We are actively seeking additional partners to sustain this initiative while the need remains, and to complement the work of all those in the public health community who are standing with the people affected by this situation.”
 
The NACDS Foundation typically focuses on fostering evidence-based research through strategic partnerships and decided to assist in Zika prevention education after discussions with public health authorities. It plans to leverage the effort by looking for additional partners to extend the campaign’s life for a year, or as needed. 
 
“I personally appreciate this meaningful work to help the people of Puerto Rico address a public health situation facing this generation and generations to come,” Puerto Rico governor Luis Fortuño said. “At times like this, the needs are great, and raising awareness is among those critical needs. I applaud the philanthropic and private entities that are playing a vital role in this emerging public health threat, like the NACDS Foundation’s campaign that will help get the word out about prevention.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA unveils tighter rules on e-cigarettes, other products

BY Gina Acosta

WASHINGTON — The U.S. Food and Drug Administration announced Thursday that it will regulate all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others.

The industry’s first federal regulations call for requiring manufacturers to disclose ingredients, banning sales of e-cigarettes to minors and requiring proof of identification for sales.

“We have more to do to help protect Americans from the dangers of tobacco and nicotine, especially our youth. As cigarette smoking among those under 18 has fallen, the use of other nicotine products, including e-cigarettes, has taken a drastic leap. All of this is creating a new generation of Americans who are at risk of addiction,” said HHS Secretary Sylvia Burwell. “Today’s announcement is an important step in the fight for a tobacco-free generation – it will help us catch up with changes in the marketplace, put into place rules that protect our kids and give adults information they need to make informed decisions.”

Before Thursday, there was no federal law prohibiting retailers from selling e-cigarettes, hookah tobacco or cigars to people under age 18. Thursday's rule changes that with provisions aimed at restricting youth access, which go into effect in 90 days, including:

  • Not allowing products to be sold to persons under the age of 18 years (both in person and online)
  • Requiring age verification by photo ID
  • Not allowing the selling of covered tobacco products in vending machines (unless in an adult-only facility)
  • Not allowing the distribution of free samples

The new rule also requires manufacturers of all newly-regulated products to show that the products meet the applicable public health standard set forth in the law and receive marketing authorization from the FDA, unless the product was on the market as of Feb. 15, 2007. The tobacco product review process gives the agency the ability to evaluate important factors such as ingredients, product design and health risks, as well as their appeal to youth and non-users.

Under staggered timelines, the FDA expects that manufacturers will continue selling their products for up to two years while they submit – and an additional year while the FDA reviews – a new tobacco product application. The FDA will issue an order granting marketing authorization where appropriate; otherwise, the product will face FDA enforcement.

Today’s actions will subject all manufacturers, importers and/or retailers of newly- regulated tobacco products to any applicable provisions, bringing them in line with other tobacco products the FDA has regulated under the TCA since 2009.

These requirements include:

  • Registering manufacturing establishments and providing product listings to the FDA
  • Reporting ingredients, and harmful and potentially harmful constituents
  • Requiring premarket review and authorization of new tobacco products by the FDA
  • Placing health warnings on product packages and advertisements
  • Not selling modified risk tobacco products (including those described as “light,” “low,” or “mild”) unless authorized by the FDA

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?